1. Downregulation of the long noncoding RNA DSCR9 (Down syndrome critical region 9) delays breast cancer progression by modulating microRNA-504-5p-dependent G protein-coupled receptor 65
    Mingzhu Li et al, 2023, Human Cell CrossRef
  2. Identification of novel anti-cancer agents, applying in silico method for SENP1 protease inhibition
    Somayye Taghvaei et al, 2022, Journal of Biomolecular Structure and Dynamics CrossRef
  3. The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications
    Yunru Gu et al, 2023, Experimental Hematology & Oncology CrossRef
  4. SENP1-mediated SUMOylation of SIRT1 affects glioma development through the NF-κB pathway
    Xin Liu et al, 2023, Experimental Cell Research CrossRef
  5. Computational study of SENP1 in cancer by novel natural compounds and ZINC database screening
    Somayye Taghvaei et al, 2023, Frontiers in Pharmacology CrossRef
  6. Emerging role of SENP1 in tumorigenesis and cancer therapy
    Min Lin et al, 2024, Frontiers in Pharmacology CrossRef
  7. Computational drug repurposing of bethanidine for SENP1 inhibition in cardiovascular diseases treatment
    Somayye Taghvaei et al, 2022, Life Sciences CrossRef
  8. SUMO‐specific proteases: SENPs in oxidative stress‐related signaling and diseases
    Yaqi Jiao et al, 2024, BioFactors CrossRef
  9. SENP1/HIF‐1α axis works in angiogenesis of human dental pulp stem cells
    Jie Zhou et al, 2020, Journal of Biochemical and Molecular Toxicology CrossRef
  10. SENP1 is required for the growth, migration, and survival of human adipose-derived stem cells
    Yingying Wu et al, 2021, Adipocyte CrossRef
  11. Understanding the Combined Effects of High Glucose Induced Hyper-Osmotic Stress and Oxygen Tension in the Progression of Tumourigenesis: From Mechanism to Anti-Cancer Therapeutics
    Gayathri K. G. et al, 2023, Cells CrossRef
  12. Transcription factor YY1 mediates self-renewal of glioblastoma stem cells through regulation of the SENP1/METTL3/MYC axis
    Jian You et al, 2023, Cancer Gene Therapy CrossRef
  13. SUMO targeting of a stress-tolerant Ulp1 SUMO protease
    Jennifer Peek et al, 2018, PLOS ONE CrossRef
  14. SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways
    Yanfang Yang et al, 2019, Cell Communication and Signaling CrossRef